Erica is our staff writer and oversees the overall content on Drugwatcher.
The Natural Products Association (NPA) recently filed a lawsuit against the U.S. Food and Drug Administration (FDA) over its position that NAC (N-acetyl-L-cysteine) cannot be included in dietary supplements. In a complaint filed in the US District Court in Maryland, NPA argues that the drug exclusion provision in the Dietary Supplement Health and Education Act […]
You might think that a widely used chemical that comes with potential dangers can easily be banned as long as there’s enough evidence to back its toxicity. But that’s not the case for the highly toxic herbicide paraquat, at least in the United States. Several countries across the globe have banned the use of paraquat […]
Whether you recently received your hernia mesh implant or you’ve had surgery years ago and now the device is giving you problems, it’s only natural to think what your next step should be. After consulting with your doctor and making sure that the hernia mesh device is indeed the cause of your side effects, you […]
Viona Pharmaceuticals, Inc., is recalling 33 lots of their Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, according to a U.S. Food and Drug Administration (FDA) announcement. The affected lots were recalled due to the presence of N-Nitrosodimethylamine, or NDMA, a contaminant that may cause cancer. It’s worth noting that in 2020, the FDA also asked […]
We opt for birth control methods because of one major reason: preventing pregnancy. But what if your contraceptive fails to perform its purpose and leaves you instead with the risk of unintended pregnancy? Plaintiffs who have filed a Paragard IUD lawsuit are all too familiar with these frustrations. Although the copper intrauterine device is more […]
Any defective medical device is bound to cause problems for a patient. In the case of hernia mesh devices, however, these potentially faulty products didn’t only cause injuries and complications. In fact, the hernia mesh lawsuit 2022 has seen an increasing number of cases being filed by patients who have suffered from several problems due […]
It’s yet another failed attempt for Biogen Inc. and its Tokyo-based partners Eisai Co. to have their controversial Alzheimer’s treatment aducanumab — this time in Japan. According to news reports, Japanese regulators concluded that inconsistent Phase III and lack of clinical evidence in reducing amyloid plaque in Alzheimer’s patients contributed to the health ministry’s pushback […]
Imagine continuously taking a drug to relieve your painful symptoms only to notice eye problems bothering you as you go on taking your medication. You then visit a doctor to have your eyes checked. According to your doctor, you have an eye condition that naturally occurs with age. So unsuspectingly, you continue taking your medicine […]
Biogen’s Aduhelm (aducanumab), the controversial Alzheimer’s drug that was recently approved in the United States, has just been rejected by the European Union’s drug regulators. According to the European Medicines Agency, aducanumab doesn’t appear to be effective at treating adults with early-stage Alzheimer’s symptoms. The regulatory authority also took issue with the medication’s side effects, […]
In every surgery, there are expected postoperative side effects. These are changes that a patient is likely to experience following a procedure. On the other hand, however, there are also some issues that are not expected to happen after a surgery. In this case, these are called complications. And although they’re unexpected and a bit […]